Riskpilot← Back to searchSign inGet full accessULLEVÅL PLASTIKKIRUGI AS
ASActiveOrg 917499802Sognsveien 75E, 0855 OsloMedical specialists activities · NACE 8622Est. 201610 employees
Revenue 2024
NOK 19,2M
+5% vs 2023
EBITDA margin
5.5%
-43% vs 2023
Equity ratio
22.2%
Financial strength
Net profit 2024
NOK 324K
-67% vs 2023
| Revenue | NOK 19,2M | +5% |
| EBITDA | NOK 1,1M | -43% |
| Net profit | NOK 324K | -67% |
| Total assets | NOK 6,5M | +47% |
| Equity | NOK 1,5M | +29% |
| Employees | 10 | — |
Legal name
ULLEVÅL PLASTIKKIRUGI AS
Org number
917499802
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
25. juli 2016
Share capital
NOK 30 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene
Company purpose
Spesialist lege senter i rekonstruktiv plastikkirurgi og hud sykdommer. Konsulterende og utøvende helsetjenester, hovedsakelig innen plastikkirurgisk fagfelt, medisinsk behandling med laser, og hud sykdommer. Rådgivning, konsultasjoner, kirurgiske operasjoner og injeksjonsbehandlinger. Salg av hudpleie produkter, og alt som står i forbindelse med dette.
Address
Sognsveien 75E, 0855 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 262 | 120 | 2 627 | 18 392 | 19 220 |
| Staff expenses | −0 | −0 | −178 | −2 289 | −4 415 |
| EBITDA | 205 | 30 | 199 | 1 865 | 1 063 |
| Depreciation & amort. | −0 | −0 | −0 | −622 | −627 |
| EBIT | 205 | 30 | 199 | 1 244 | 435 |
| Net financials | 0 | −0 | −31 | −2 | −15 |
| Profit before tax | 205 | 29 | 168 | 1 241 | 420 |
| Tax | 6 | −0 | 37 | 273 | 96 |
| Net profit | 199 | 29 | 131 | 968 | 324 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 187 | 153 | 1 281 | 4 449 | 6 531 |
| Equity | 0 | 29 | 160 | 1 128 | 1 452 |
| Long-term debt | 2 | 2 | 560 | 356 | 797 |
| Short-term debt | 184 | 122 | 560 | 2 965 | 4 282 |
| Total debt | 186 | 124 | 1 121 | 3 321 | 5 079 |
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
20202024
Equity ratio
22.2%
This company
38.2%
Market median
-42% vs market
20202024
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20202024
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20202024
Asset turnover
2.94×
This company
1.12×
Market median
+162% vs market
20202024
Debt / equity
3.50×
This company
0.62×
Market median
-465% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ULLEVÅL PLASTIKKIRUGI AS 
UNITED MEDICAL GROUP ASBoard members of ULLEVÅL PLASTIKKIRUGI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alex Pujari | Chairman | 0 companies |